Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer PatientsStatus: open
[794424-7] A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Treatment for Breast Cancer
This randomized phase III trial studies axillary lymph node dissection to see how well it works compared to axillary radiation therapy in treating patients with node-positive breast cancer treated with neoadjuvant chemotherapy followed by surgery. Lymph node dissection may remove cancer cells that have spread to nearby lymph nodes in patients with breast cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. This study will evaluate whether radiation therapy is as effective as lymph node dissection. IRB Number 15-197
SponsorsThis trial is sponsored by Alliance for Clinical Trials in Oncology.
Interested in Clinical Trial?
Providers Associated With This Trial
- Donna Lynn Dyess, M.D.Breast/Endocrine SurgeonProfessor of Surgery